Snowball logo
logo
0645

Bioneer Corporation

064550 KQ
7,310.000.00  (0%)
Estimate
Beta
-0.228
Growth
Revenue, YoY
10.69%
Net income, YoY
-2,387.57%
FCF, YoY
112.49%
Forecast
P/E (FWD)
2.8
EPS (FWD)
2,634
About the company
Ticker
064550
ISIN
KR7064550007
Country
South Korea
Sector (GICS)
Healthcare
Bioneer Corporation engages in the biotechnology research products, molecular diagnosis, drugs, and probiotics businesses in South Korea. The company offers PCR and RT-PCR, real-time PCR, RNAi, chemicals, plastic consumables, and buffer solutions; and sample preparation, protein synthesis and purification, gene cloning, fluorescence dye and quencher, electrophoresis, genome-wide functional analysis, and magnetic separation services, as well as instruments for conventional PCR, real-time PCR, sample preparation, protein synthesis, centrifuge and vortex mixer, electrophoresis, spectrophotometer, and microbial culture. It also provides molecular diagnosis, including MDx technologies, human diagnostics kits, MDx extraction kits, and instruments; and products for animal diseases and nano-bio products. The company was founded in 1992 and is headquartered in Daejeon, South Korea.

Frequently asked questions

What sector does Bioneer Corporation (064550) operate in?

Bioneer Corporation belongs to the Healthcare sector and operates in the Biotechnology & Medical Research industry.

What is Bioneer Corporation (064550) current stock price?

As of the latest data, Bioneer Corporation stock price is ₩7,310, with a previous close of ₩7,310.

What is Bioneer Corporation (064550) current market capitalization?

Bioneer Corporation market cap is approximately 161.53 billion.

Does Bioneer Corporation (064550) pay dividends?

No. Bioneer Corporation does not pay a dividend.

What is Bioneer Corporation (064550) beta (volatility) score?

Bioneer Corporation has a beta of -0.228, indicating lower volatility than the overall market.